North East London: NHS GLP-1 access

Major areas covered

Newham · Tower Hamlets · Hackney · Waltham Forest · Barking and Dagenham · Havering · Redbridge · City of London

Highest-population London ICB. Very diverse demographic profile; ethnicity-adjusted BMI eligibility applies to a large share of the population.

Rollout cohort framework (national)

• Cohort 1 (live since June 2025): BMI 40+ (37.5+ with ethnicity adjustment) and four or more weight-related comorbidities. Operationalised through Specialist Weight Management Service referral.
• Cohort 2 (launches 23 June 2026): BMI 35+ (32.5+ with ethnicity adjustment) and three or more comorbidities.
• Cohort 3 (expected April 2027): BMI 30+ (27.5+ with ethnicity adjustment) and two or more comorbidities.

Local pace varies. Some ICBs commissioned tier-3 capacity ahead of June 2025 and ran ready; others took six to twelve months to scale. Capacity at the local Specialist Weight Management Service is the binding constraint in most areas. PeptideClear\'s central rollout tracker documents known pace data per region; per-ICB granular data is added as ICBs publish.

How NHS referral works in North East London

The standard NHS pathway for patients meeting current-cohort criteria starts with the GP. The GP confirms BMI, ethnicity adjustment where applicable, and comorbidity count, then refers to the local Specialist Weight Management Service. The service runs the assessment, prescribes the medication if the patient is suitable, and provides the structured 12-month programme that includes lifestyle support alongside the medication.

Stopping rule: patients must achieve at least 5 percent weight loss from baseline by month 6 for NHS Mounjaro to continue under TA1026. Private prescribing operates outside this stopping rule and follows its own continuation criteria.

Private alternatives

Private prescribing operates independently of the NHS cohort framework. UK clinics and pharmacies can prescribe tirzepatide and semaglutide based on their own clinical criteria, typically aligned to MHRA SPCs (BMI 30+ for Wegovy, BMI 30+ for Mounjaro weight management, BMI 27+ with comorbidities).

• · High-touch UK clinics (Numan, Voy, Manual, Juniper) bundle prescribing with coaching from £199 to £299 per month.
• · Low-touch UK pharmacies (Phlo, SimplyMeds, Boots Online Doctor, Asda Online Doctor, Pharmacy2U) dispense via questionnaire from £149 per month.
• · UK delivery is nationwide from all listed providers. The provider does not have to be in the same ICB as the patient.

Neighbouring ICBs